Pharmagreen Biotech Inc

Company Profile

Pharmagreen Biotech Inc had its IPO on under the ticker symbol PHBI.

The company operates in the Healthcare sector and Drug Manufacturers-Specialty & Generic industry. Pharmagreen Biotech Inc has a staff strength of 0 employees.

Stock update

Shares of Pharmagreen Biotech Inc opened at $0 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $0 - $0, and closed at $0.

This is a -20% slip from the previous day's closing price.

A total volume of 2,350,698 shares were traded at the close of the day’s session.

In the last one week, shares of Pharmagreen Biotech Inc have slipped by -20%.

Pharmagreen Biotech Inc's Key Ratios

Pharmagreen Biotech Inc has a market cap of $551607, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Pharmagreen Biotech Inc’s revenue was $1560 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures Pharmagreen Biotech Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Pharmagreen Biotech Inc’s operating margin was -35807.05% while its return on assets stood at -210.64% with a return of equity of 0%.

In Q2, Pharmagreen Biotech Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Pharmagreen Biotech Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Pharmagreen Biotech Inc’s profitability.

Pharmagreen Biotech Inc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of -2.0203. Its price to sales ratio in the trailing 12-months stood at 0.

Pharmagreen Biotech Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$140313.00

Total Liabilities

$2.17 million

Operating Cash Flow

$0

Capital Expenditure

$0

Dividend Payout Ratio

0%

Pharmagreen Biotech Inc ended 2024 with $140313.00 in total assets and $0 in total liabilities. Its intangible assets were valued at $140313.00 while shareholder equity stood at $-2104324.00.

Pharmagreen Biotech Inc ended 2024 with $0 in deferred long-term liabilities, $2.17 million in other current liabilities, 463961.00 in common stock, $-12965156.00 in retained earnings and $0 in goodwill. Its cash balance stood at $5315.00 and cash and short-term investments were $5315.00. The company’s total short-term debt was $279,871 while long-term debt stood at $119603.00.

Pharmagreen Biotech Inc’s total current assets stands at $51463.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $606.00 compared to accounts payable of $697110.00 and inventory worth $9247.00.

In 2024, Pharmagreen Biotech Inc's operating cash flow was $0 while its capital expenditure stood at $0.

Comparatively, Pharmagreen Biotech Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$0

52-Week High

$0.015

52-Week Low

$0.0007

Analyst Target Price

$

Pharmagreen Biotech Inc stock is currently trading at $0 per share. It touched a 52-week high of $0.015 and a 52-week low of $0.015. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 1863.3% of the company’s stock are held by insiders while 0% are held by institutions.